Pulmonary Medicine
Annals of Medicine
In the Pulmonary Medicine section of Annals of Medicine we consider for publication the latest advances in:
| Alpha-1 Antitrypsin Deficiency | Asthma | Chronic Obstructive Pulmonary Disease (COPD) | Cystic Fibrosis |
| Emphysema | Infectious Diseases | Interstitial Lung Disease (ILD) | Lung Cancer |
| Lung Physiopathology | Respiratory Failure | Sleep Apnea |
In addition, this section focuses on innovation that fosters discussion to push the boundaries of knowledge in all areas covered by this discipline.
Annals of Medicine
Q1 Rank
Two-Year Impact Factor 3.243
Five-Year Impact Factor 3.840
MEDLINE® Indexed
CiteScore 5.70
Meet the Section Editor
Laura Pini, MD, Professor of Respiratory Medicine, Department of Clinical and Experimental Sciences, University Hospital of Brescia, Italy
Professor Pini completed her Post-Doc at the Meakins Christie Laboratory, McGill University, Canada in 2005 where her research primarily focused on airway remodeling. Pini's research interests include lung pathophysiology, airway remodeling, severeal asthma and alpha-1 antitrypsin deficiency. Pini has contributed to several national and international pharmacological studies and published more than 100 peer-reviewed articles. Professor Pini is currently an active member of the European Respiratory Society, the European Alpha-1 antitrypsin deficiency Award (e-ALTA) Network, the Severe Asthma Network in Ital (SANI) and the Severe Heterogenous Asthma Research (SHARP) Clinical Research Collaboration. Pini also lectures and supervises medical residents enrolled in the University's Respiratory Medicine Program.
Why is Annals of Medicine the Best Publication for Your Research?
Fully open access, general medical journal publishing articles under a CC BY license, allowing maximum sharing and reuse of articles to our international readership;
Publishing all scientifically valid research, including reporting of negative and null data, from translational to clinical research in all disciplines and therapy areas;
Led by an international editorial team of subject experts who ensure a constructive and rigorous peer review process;
Your research is promoted via a tailored, multi-channel approach to maximize visibility, readership and impact.
